Course Information

« Back to Course Archive

MMI/Pfizer Course: Molecules to Medicines - How Biopharma Delivers - DAY 1

Title: MMI/Pfizer Course: Molecules to Medicines - How Biopharma Delivers - DAY 1

Date(s): 20 November 2012

Main Venue:
Royal College of Surgeons in Ireland
123 St Stephens Green, Dublin 2

Location »


Online Application Period: 16 Oct - 19 Nov

 

 

 

 

 

 
 Read a report of the 2012 Molecules to Medicines course here
 

 


Quicklink to items on this page:

Programme

Faculty 

To apply 

This MMI/Pfizer Course will be of interest to research students, academic staff and clinicians, whether contemplating a career in industry or doing translational research in academia. It will also be of interest to those already working in a commercial setting with an interest in the biopharmaceutical industry.

The lectures provide an overview of biopharmaceutical discovery, development and manufacturing, delivered by key staff from Pfizer.

Course/Workshop Developers:
Senior Staff from Pfizer (please see at the bottom of this page)


Lecture course Fees (does not include Workshop)
 

  • Academic Rate: No Charge
  • Non-academic rate: 300 Euros
     

The registration charges do not include accommodation or travel. Please contact education@molecularmedicineireland.ie for further information


Please note that in addition to the lecture course, there is a MMI/Pfizer Molecules to Medicines Workshop usually taking place on the day following the lecture course.

In the first instance this workshop is open to postgraduate students with research experience (e.g. at least one year into their PhD studies). There are a limited number of places available on the workshop. If places are available we will open attendance to postdoctoral staff also.

If you are interested in attending this workshop please send an email indicating your interest to education@MolecularMedicineIreland.ie after you have applied online for the lecture course (Attendance to the lecture course is compulsory in order to attend the workshop).

Please see here for further details on the workshop

A follow-up visit to the Pfizer Biotech campus at Grange Castle is also organised for a limited group of course attendees. Please also indicate whether you wish to attend the Pfizer Grange Castle Facility Tour when applying for the workshop.

 

Comments from participants on a previous run of the Lecture Course:

"This was a thoroughly enjoyable course, well recommended and superbly organized".

"I have already recommended to many people who can be interested".

"Extremely informative and enjoyable two days. Well impressed". 

 


 

1000 Introduction
 

DISCOVERY
Dr Jonny Finlay (Pfizer)

1005 Introduction to the business of discovering biopharmaceuticals
1055 Coffee/Tea
1115 Current biopharmaceutical product candidates and a look into next generation technologies
   
  DEVELOPMENT
Dr Patrick Gammel (Pfizer)
1205 Current issues within the biopharmaceutical and how these are influencing development within the industry
1255 Lunch break (lunch will be provided)
1340 Cell line & Process development
   
  MANUFACTURING
Dr Brian Hasset (Pfizer)
1430 Introduction to the science and technology of biopharmaceutical manufacturing
1520 Coffee/Tea
1540 Focus on the application of molecular technologies in manufacturing environments
   
1630 Discussion & round up
 
Click here for abstracts & biographies
  Back to top

 


Course Faculty

Dr Jonny Finlay (Global Biologic Therapeutics, Grange Castle, Ireland)
Dr Patrick Gammell (Principal Process Development Scientist, Pfizer Grange Castle, Ireland)
Dr Brian Hassett (Principal Scientist, Development Analytical Sciences, Pfizer)

 

The Molecules to Medicines Course and Workshop were originally initiated in 2006 as a collaboration with Wyeth Biopharma. They were first developped and delivered by Dr Davinder Gill (then Assistant Vice President, Biologic Therapeutics, Wyeth Pharmaceuticals, Cambridge, MA, USA), Dr Brendan Hughes (then Director of Development, Wyeth Medica Ireland, Grange Castle) & Dr Mark Leonard (then Director, Gene Expression Technologies, Wyeth BioPharma Campus, Andover, MA, USA).